These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 33764690)
21. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT. Yang J; Qin G; Luo M; Chen J; Zhang Q; Li L; Pan L; Qin S Cell Death Dis; 2015 Jul; 6(7):e1829. PubMed ID: 26203858 [TBL] [Abstract][Full Text] [Related]
22. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition. Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987 [TBL] [Abstract][Full Text] [Related]
23. miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells. Nishijima N; Seike M; Soeno C; Chiba M; Miyanaga A; Noro R; Sugano T; Matsumoto M; Kubota K; Gemma A Int J Oncol; 2016 Mar; 48(3):937-44. PubMed ID: 26783187 [TBL] [Abstract][Full Text] [Related]
24. Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway. Guan Y; Zhang J; Cai X; Cai Y; Song Z; Huang Y; Qian W; Pan Z; Zhang X Gene; 2024 Mar; 897():148040. PubMed ID: 38065426 [TBL] [Abstract][Full Text] [Related]
25. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells. Yao W; Wang L; Huang H; Li X; Wang P; Mi K; Cheng J; Liu H; Gu C; Huang L; Huang J BMC Cancer; 2020 Apr; 20(1):315. PubMed ID: 32293355 [TBL] [Abstract][Full Text] [Related]
26. miR-145-5p Targets Sp1 in Non-Small Cell Lung Cancer Cells and Links to BMI1 Induced Pemetrexed Resistance and Epithelial-Mesenchymal Transition. Chang WW; Wang BY; Chen SH; Chien PJ; Sheu GT; Lin CH Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499676 [TBL] [Abstract][Full Text] [Related]
27. Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells. Vad-Nielsen J; Gammelgaard KR; Daugaard TF; Nielsen AL Lung Cancer; 2019 Jun; 132():132-140. PubMed ID: 31097086 [TBL] [Abstract][Full Text] [Related]
29. Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib. Hashida S; Yamamoto H; Shien K; Miyoshi Y; Ohtsuka T; Suzawa K; Watanabe M; Maki Y; Soh J; Asano H; Tsukuda K; Miyoshi S; Toyooka S Cancer Sci; 2015 Oct; 106(10):1377-84. PubMed ID: 26202045 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells. Wang M; Zhang R; Zhang S; Xu R; Yang Q Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930 [TBL] [Abstract][Full Text] [Related]
31. Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells. Liao CH; Tzeng YT; Lai GM; Chang CL; Hu MH; Tsai WL; Liu YR; Hsia S; Chuang SE; Chiou TJ; Wang LM; Whang-Peng J; Yao CJ Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32751169 [TBL] [Abstract][Full Text] [Related]
32. The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma. Tsai SC; Lin CC; Shih TC; Tseng RJ; Yu MC; Lin YJ; Hsieh SY Mol Carcinog; 2017 Sep; 56(9):2035-2047. PubMed ID: 28383782 [TBL] [Abstract][Full Text] [Related]
33. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238 [TBL] [Abstract][Full Text] [Related]
34. Effect of ZEB1 Associated with microRNAs on Tumor Stem Cells in Head and Neck Cancer. Ferreira LAM; Bezerra MADS; Kawasaki-Oyama RS; Fernandes GMM; Castanhole-Nunes MMU; Serafim Junior V; Castilho RM; Pavarino ÉC; Maniglia JV; Goloni-Bertollo EM Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982993 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764 [TBL] [Abstract][Full Text] [Related]
36. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties. Si J; Ma Y; Bi JW; Xiong Y; Lv C; Li S; Wu N; Yang Y J Exp Clin Cancer Res; 2019 Dec; 38(1):481. PubMed ID: 31801598 [TBL] [Abstract][Full Text] [Related]
37. MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway. Jiang J; Feng X; Zhou W; Wu Y; Yang Y Oncotarget; 2016 Nov; 7(45):73188-73199. PubMed ID: 27690301 [TBL] [Abstract][Full Text] [Related]
38. Zeb1 Regulates the Symmetric Division of Mouse Lewis Lung Carcinoma Stem Cells through Numb mediated by miR-31. Wang J; Zhou T; Sun Z; Ye T; Zhou S; Li J; Liu Y; Kong L; Tang J; Liu D; Xing HR Int J Biol Sci; 2018; 14(11):1399-1410. PubMed ID: 30262992 [TBL] [Abstract][Full Text] [Related]
39. Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features. Sato H; Shien K; Tomida S; Okayasu K; Suzawa K; Hashida S; Torigoe H; Watanabe M; Yamamoto H; Soh J; Asano H; Tsukuda K; Miyoshi S; Toyooka S Sci Rep; 2017 Jan; 7():40847. PubMed ID: 28084458 [TBL] [Abstract][Full Text] [Related]
40. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]